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        Appropriate regulation of immune homeosta-
sis is critical for ensuring adequate immunity 
toward harmful pathogens without uncontrolled 
infl  ammation that could lead to tissue damage. 
T reg cells have a critical role in homeostasis 
by suppressing the activation of autoreactive 
T cells. Either mutations in the gene encod-
ing Foxp3, a transcription factor required for 
T reg cell diff  erentiation, or ablation of T reg 
cells results in devastating autoimmune lympho-
proliferative disease (  1  –  4  ). Chronic infl  amma-
tion and autoimmunity can also result from 
defective activation of apoptosis that is nor-
mally required for the contraction of eff  ector 
T cells after an immune response (  5  –  7  ). Dys-
regulated cytokine signaling can also lead to 
spontaneous T cell activation and infl  amma-
tory disease, independently of antigen stimu-
lation (  8  –  10  ). 
  A hallmark of T reg cells is the expression of 
the forkhead transcription factor Foxp3.   “  Natu-
ral  ”   Foxp3-expressing T cells arise in the thymus 
from a subset of thymocytes selected on class II 
MHC (  11  ). Expression of Foxp3 is also induced 
in naive CD4  +   T cells in response to antigen 
stimulation in the presence of TGF-    . These 
inducible T reg cells have also been shown to 
have suppressive activities (  12  ). 
  The decision of precursor cells to diff  eren-
tiate into phenotypically and functionally dis-
tinct lineages, such as occurs when immature 
CD4  +  8  +   double-positive (DP) thymocytes dif-
ferentiate into cytotoxic CD8  +  , helper CD4  +  , 
or regulatory Foxp3  +   T cells, is ultimately 
governed by the regulation of gene expression 
in response to intrinsic or extrinsic signals. Gene 
expression is regulated at multiple levels, from 
chromatin organization to transcription to post-
transcriptional controls. It is now clear that not 
only proteins but also small regulatory RNAs play 
critical roles at each of these levels of regulation. 
  MicroRNAs (miRNAs) are short (    22 nt) 
noncoding RNAs, expressed from endoge-
nous genes, that act on target protein  –  encoding 
mRNAs through the RNA-induced silencing 
complex, targeting them for translational re-
pression or degradation (  13  ). The biogenesis of 
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  MicroRNAs (miRNAs) are implicated in the differentiation and function of many cell types. 
We provide genetic and in vivo evidence that the two RNaseIII enzymes, Drosha and Dicer, do 
indeed function in the same pathway. These have previously been shown to mediate the 
stepwise maturation of miRNAs (Lee, Y., C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, 
P. Provost, O. Radmark, S. Kim, and V.N. Kim. 2003.   Nature  . 425:415  –  419), and genetic abla-
tion of either within the T cell compartment, or specifi  cally within Foxp3  +   regulatory T (T reg) 
cells, results in identical phenotypes. We found that miRNA biogenesis is indispensable for the 
function of T reg cells. Specifi  c deletion of either   Drosha   or   Dicer   phenocopies mice lacking a 
functional   Foxp3   gene or Foxp3  +   cells, whereas deletion throughout the T cell compartment 
also results in spontaneous infl  ammatory disease, but later in life. Thus, miRNA-dependent 
regulation is critical for preventing spontaneous infl  ammation and autoimmunity. 
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    RESULTS   
  Specifi  c miRNA defi  ciency in mice with Drosha defi  ciency 
in the T cell compartment 
  The mouse   Drosha   gene (also known as   Rnasen   or   Etohi2  ) 
consists of 35 exons spanning 110 kb on chromosome 15 
(Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20081219/DC1). The full-length Drosha transcript 
was predicted to be 4.5 kb and to encode a 1,373-residue 
polypeptide (Fig. S1 B). However, an initial survey of expressed 
sequence tags that mapped to the   Drosha   locus suggested that 
multiple splice isoforms might exist. By using sequential primer 
pairs to amplify cDNA reverse transcribed from various mouse 
tissues, two alternately spliced isoforms were identifi  ed in ad-
dition to the full-length transcript. These were products of 
splicing between exons 2 and 7 and exons 4 and 7 of the pri-
mary transcript (Fig. S1, C and D). Although the full-length 
transcript was always the predominant species, both alter-
nately spliced isoforms were predicted to be in frame. We 
therefore used a targeting strategy that would disrupt all three 
potential Drosha transcripts. By gene targeting in embryonic 
stem cells, a conditional   Drosha   allele (F) was generated by 
fl  anking exon 9 with LoxP sites (Fig. S2 A), which if deleted 
was predicted to cause a frame shift and the appearance of 
multiple stop codons in exon 11. Mice were generated from 
these cells, and subsequent recombination of the conditional 
allele in the germ line yielded the null allele (    ; Fig. S2 B). 
  Heterozygous   Drosha  F/        mice, which harbor only one 
functional Drosha allele, were viable. These were bred with 
transgenic mice expressing cre under regulation of the CD4 
promoter/enhancer/silencer (  25  ). Mice were maintained as 
  Drosha  F/        heterozygotes to ensure effi   cient deletion when-
ever cre was expressed. CD4-cre effi   ciently recombined the 
conditional allele at the DNA and transcript levels at the DP 
thymocyte stage. Deletion of the conditional allele was simi-
larly observed in mature peripheral T cells, indicating that 
there was no preferential selection of cells that had failed to 
undergo recombination at the   Drosha   locus (  Fig. 1 A   and Fig. 
S2 C).   Expression of the full-length Drosha protein, which 
was the only isoform detected in wild-type lymphocytes by 
Western blotting, was markedly reduced in DP thymocytes 
and was completely absent from mature T cells in   Drosha  F/      
CD4-cre   mice. This resulted in the loss of pre-miRNAs and 
mature miRNAs specifi  cally in T cells (  Fig. 1 C  ). However, 
the expression of some mature miRNAs, such as miR-29a, 
was only partially down-regulated in the absence of Drosha, 
suggesting that diff  erent miRNA species may have diff  erent 
stabilities. Consistent with a function for the processing of 
pri-miRNA, an accumulation of pri  –  miR-150 transcript was 
detected in Drosha-defi  cient T cells (  Fig. 1 D  ). 
  It was previously suggested that Drosha might be required 
for processing of the pre-rRNA transcript into the smaller ri-
bosomal subunits (  24  ). However, we found no diff  erence in 
the level of   28S  ,   18S  ,   5.8S  , and   5S   rRNAs expressed in Dro-
sha-defi  cient T cells compared with control cells (  Fig. 1, C 
and D  ). Therefore, Drosha appears to be specifi  c for the pro-
cessing of pri-miRNA transcripts. 
miRNAs involves two processing steps that have been 
largely defi  ned in cell-based and biochemical studies. Pri-
mary miRNA (pri-miRNA) transcripts are fi  rst cleaved by 
the nuclear   “  microprocessor  ”   complex containing the RNaseIII 
enzyme Drosha and its double-stranded RNA (dsRNA) 
binding partner DGCR8/Pasha, leaving short hairpin pre-
miRNAs (  14, 15  ). These pre-miRNAs are then exported to 
the cytoplasm, where they are further processed by another 
RNaseIII enzyme, Dicer, and its dsRNA binding partner, 
TRBP, to liberate the mature miRNAs for loading into the 
RNA-induced silencing complex (  16  ). 
  Genetic studies have clearly demonstrated a critical re-
quirement for Dicer in vivo  .   Dicer defi  ciency in the nematode 
  Caenorhabditis elegans   causes sterility (  17  ), whereas defi  ciency 
in mice results in early embryonic lethality (  18  ). Dicer has 
also been shown to have critical functions in the diff  erentia-
tion of specifi  c tissues, such as skeletal muscle (  19  ), pancreatic 
islets (  20  ), and B lymphocytes (  21  ). The function of Dicer, 
however, is not limited to miRNA biogenesis. Dicer is also 
required for the generation of small inhibitory RNAs (si-
RNAs) derived from endogenous dsRNA transcripts or exog-
enous sources of dsRNAs, including viruses and experimental 
siRNAs. siRNAs derived from endogenous dsRNAs may 
also play important roles in gene regulation. siRNAs gener-
ated from pseudogene-derived dsRNAs may regulate com-
plementary protein  –  coding transcripts, analogous to miRNAs, 
whereas siRNAs from retrotranspon-derived dsRNAs appear 
to be important for genome stability (  22, 23  ). Thus, although 
the loss of miRNA-dependent regulation is implicated in the 
phenotypes caused by Dicer defi  ciency, it is not known whether 
they are a consequence solely of the loss of miRNAs or if the 
loss of other Dicer functions also contributes. 
  Unlike Dicer, Drosha is thought to be required for the 
biogenesis of miRNAs but not in the generation of other 
siRNAs. However, an early report suggested that this RNas-
eIII enzyme is required for processing of the preribosomal 
RNA (pre-rRNA) (  24  ). To investigate specifi  cally the func-
tion of miRNA-dependent regulation, we generated mice 
with a targeted conditional   LoxP   allele of the   Drosha   gene 
and compared these with mice with a conditional   LoxP   allele 
of   Dicer  . By specifi  cally inactivating these genes in T lym-
phocytes, we found that Drosha is indeed required for the 
biogenesis of miRNAs but not for the expression of rRNA 
subunits. Both Drosha- and Dicer-dependent pathways 
were critical for the induction of Foxp3 and function of the 
T reg lineage. Consequently, the loss of Drosha throughout 
the T cell compartment resulted in spontaneous T cell acti-
vation, infl  ammatory disease, and premature lethality. The 
absence of either Drosha or Dicer specifi  cally in Foxp3  +   T 
reg cells was even more devastating, resulting in early on-
set lymphoproliferative disease, analogous to Foxp3 or T 
reg defi  ciency. Thus, we provide the fi  rst genetic and in vivo 
evidence that Drosha and Dicer function in the same path-
way, and that this pathway, in the biogenesis of miRNAs, is 
critical for immune regulation and preventing lethal infl  am-
matory disease. JEM VOL. 205, September 1, 2008 
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ferentiation (  Fig. 2, B and D  ). One subtle diff  erence observed 
was a reduction in the frequency of TCR      +   thymocytes that 
had down-regulated CD24 and CD69 (  Fig. 2 C  ), suggesting 
a partial perturbation in the ability of Drosha-defi  cient thy-
mocytes to mature after selection. 
  Although thymocyte subpopulation profi  les appeared nor-
mal, absolute numbers of DP and mature thymocytes were 
signifi  cantly reduced with Drosha defi  ciency (  Fig. 2 G  ). This 
  Drosha defi  ciency at the DP thymocyte stage results 
in T lymphopenia 
  A reduction in the number of total thymocytes was observed 
in   Drosha  F/      CD4-cre   mice at 6 wk of age (  Fig. 2 A  ).   An anal-
ysis of cell surface markers did not reveal a loss of any par-
ticular thymocyte subpopulation. TCR      hi   versus TCR          +   
populations appeared similar to littermate controls, as did ex-
pression of CD4 and CD8 at various stages of thymocyte dif-
    Figure 1.         Drosha defi  ciency abrogates miRNA but not rRNA processing.   (A) CD4-cre effi  ciently deletes exon 9 from the conditional Drosha tran-
script from the DP thymocyte stage onwards. cDNA from the indicated populations was analyzed for expression of the Drosha exons 5/6 or exon 9/10 junc-
tion by quantitative RT-PCR. DN4, CD90  + TCR   lo CD4/8/44/25      ; DP, CD4  + 8 +  ; CD4SP, TCR    hi CD24 lo 4 + 8      ; CD8SP, TCR    hi CD24 lo 4     8 +  . (B) Drosha protein 
expression in DP thymocytes, and peripheral TCR    +   T cells and B220  +   B cells from   Drosha  F/    CD4-cre   and control   Drosha  F/+  CD4-cre   mice. Molecular weights 
are shown. (C) Total RNA from DP thymocytes and peripheral T and B cells was resolved on a polyacrylamide gel and Northern blotted for expression of 
mature miRNAs. Also shown is the ethidium bromide gel for expression of small rRNA and transfer RNA species. (D) Total RNA was resolved on an agarose-
formaldehyde gel and Northern blotted for expression of pri-miR-150. Also shown is the ethidium bromide gel for expression of the large rRNA subunits.     2008 DROSHA AND DICER REQUIREMENT FOR T REG CELL FUNCTION   | Chong et al. 
mice and various littermate controls was monitored in a long-
term survival study. From around 4 mo of age, cachexia was 
observed in many of the   Drosha  F/      CD4-cre   mice. These be-
came moribund soon thereafter, at which point they were killed 
with littermate controls for analysis. By 6 mo, there was a 50% 
mortality rate in the   Drosha  F/      CD4-cre   group (  Fig. 3 A  ).   
  A reduction in muscle mass and a complete loss of visceral 
adipose tissue was evident in all moribund   Drosha  F/      CD4-cre   
mice. A substantial increase in the frequency of activated 
(CD62L  lo  44  hi  ) CD4  +   T cells was observed in the spleen and 
lymph nodes (  Fig. 3 B  ). Furthermore, very high frequencies of 
IFN-      –   and IL-17A  –  secreting cells were observed (  Fig. 3 C  ). 
IL-17A expression was particularly prominent, as signifi  cant 
levels of IL-17A are normally only observed at mucosal 
translated into a reduction in the number of mature T cells 
found in the periphery (  Fig. 2, E and G  ). Furthermore, al-
though the ratio of CD4 to CD8 mature thymocytes was simi-
lar between   Drosha  F/      CD4-cre   mice and littermate controls, 
there was a signifi  cant reduction in the frequency of mature 
CD8  +   T cells in the periphery (  Fig. 2, F and H  ). Thus, T cell  –
  specifi  c Drosha defi  ciency results in T lymphopenia, particu-
larly in the CD8  +   compartment, and suggests a requirement 
for miRNAs in the homeostasis of mature T cells. 
  T cell  –  specifi  c defi  ciency results in spontaneous 
infl  ammatory disease and premature mortality 
  To investigate the consequence of losing Drosha-dependent 
regulatory pathways in T cells, a cohort of   Drosha  F/      CD4-cre   
    Figure 2.         Drosha defi  ciency at the DP thymocyte stage partially perturbs thymocyte output.   (A) Total thymocyte and splenocyte numbers in   Dro-
sha  F/    CD4-cre   and   Drosha  F/+  CD4-cre   (control) mice. (B) TCR     versus  TCR      expression on total thymocytes. (C) CD24 and CD69 expression on TCR    hi   gated 
thymocytes. (D) CD4 versus CD8 expression on total, postselected (TCR    hi CD24 hi /69 +  ) and mature (TCR    hi CD24 lo /69      ) thymocytes. (E and F) FACS analysis of 
populations in total splenocytes (E) and TCR    +   splenocytes (F). Also shown is the effect of Dicer defi  ciency. Percentages of cells are shown in B  –  F. (G) Abso-
lute CD4  + 8 +   DP, mature thymocyte, and TCR    +   splenocyte numbers. (H) CD4/CD8 ratio in the mature thymocyte and TCR    +   splenocyte  compartments.   JEM VOL. 205, September 1, 2008 
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in the frequency of IFN-      +    –  or IL-17A  –  secreting CD4  +   T 
cells could already be detected in   Drosha  F/      CD4-cre   mice at 
3 mo of age (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20081219/DC1), suggesting a gradual ac-
cumulation of infl  ammatory cells in aging mice. Consistent 
with aberrant IL-17A expression, there was a signifi  cant in-
crease in the frequency of granulocytes in these lymphoid 
surfaces, such as the small intestine, and in some autoimmune 
diseases, such as in experimental autoimmune encephalomy-
elitis (  26, 27  ). Another prominent feature in moribund   Dro-
sha  F/      CD4-cre   mice was the presence of a high frequency of 
IFN-    /IL-17A double-secreting cells (  Fig. 3 E  ), which has 
also been observed in autoimmune models such as experi-
mental autoimmune encephalomyelitis. A marginal increase 
    Figure 3.         T cell  –  specifi  c Drosha defi  ciency results in spontaneous infl  ammatory disease and premature mortality.   (A) Kaplan-Meyer survival 
plot of   Drosha  F/    CD4-cre   and control mice (  Drosha  F/F  ,   Drosha       /+   , or   Drosha  F/+  CD4-cre  ). (B) Aberrant activation of CD4  +   T cells in lymphoid organs of 
moribund   Drosha  F/    CD4-cre   mice. (C and D) Cytokine expression by CD4  +   (C) and CD8  +   (D) T cells. (E) Frequent IFN-     and IL-17A coexpression by CD4  +  
T cells. (F) Granulocyte (Gr-1  + )  and       T cells populations in lymphoid organs. Percentages of cells are shown in B  –  F. (G) H  &  E-stained sections of the 
lung (i and iii) and liver (ii, iv, and v). Bars, 100   μ  m.     2010 DROSHA AND DICER REQUIREMENT FOR T REG CELL FUNCTION   | Chong et al. 
organs (  Fig. 3 F  ). An increase in         T cells was also observed. 
Aberrant activation and cytokine secretion by CD8  +   T cells 
was usually not observed in these mice (  Fig. 3, B and D  ). 
  The liver and lung appeared to be the major organs af-
fected by infl  ammation (  Fig. 3 G  ; and Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20081219/DC1). 
Infi  ltrating cells also accumulated in the lung, primarily around 
blood vessels, resulting in epithelial thickening of the sur-
rounding tissue. Infi  ltrating cells accumulated around most 
vessels in the liver, with additional foci of infl  ammatory cells 
evident throughout the sinusoids (  Fig. 3 G  , v). In addition, 
small foci of infl  ammatory cells were more prevalent in the 
small intestine and colon of   Drosha  F/      CD4-cre   mice compared 
with littermate controls. 
  Despite aberrant CD4  +   T cell activation, infl  ammatory cy-
tokine secretion, and tissue infl  ammation, the spleen and lymph 
nodes of   Drosha  F/      CD4-cre   mice were no larger than those in 
littermate controls (Fig. S4, A and B, available at http://www
.jem.org/cgi/content/full/jem.20081219/DC1). In fact, the 
reduced thymic output and T lymphopenia remained a feature 
of these older mice (Fig. S4, C  –  E). Thus, T cell  –  specifi  c Dro-
sha defi  ciency results in lethal infl  ammatory disease associated 
with lymphopenia. 
  Drosha-dependent pathways are required for the induced 
Foxp3 expression and suppressive activity of T reg cells 
  It was previously suggested that Foxp3 contributes to the 
miRNA signature in T reg cells and that miRNA pathways 
contribute to the regulation of Foxp3 expression (  28  ). Indeed, 
a reduction in the frequency of Foxp3  +   thymocytes and ma-
ture peripheral T reg cells was observed in both   Drosha  F/      
CD4-cre   and   Dicer  F/F   CD4-cre   conditional-defi  cient mice (  Fig. 
4 A  ).   This reduction was not simply concurrent with the gen-
eral T lymphopenia, because it was still evident when examin-
ing only the CD4  +   compartment (  Fig. 4 B  ). With both Drosha 
and Dicer defi  ciency, the reduction in the T reg cell popula-
tion was largely caused by a loss of the Foxp3  +  CD25  lo   cells. 
  Foxp3 expression can also be induced in naive CD4  +   T 
cells upon antigen stimulation in the presence of TGF-    , and 
this expression is enhanced and stabilized by retinoic acid 
(  29, 30  ). To examine if Drosha- and Dicer-dependent pathways 
may also be required for inducible T reg cells, naive CD4  +   T 
cells were purifi  ed from   Drosha  F/      CD4-cre   and   Dicer  F/F   CD4-
cre   mice and were activated in vitro in the presence of TGF-     
(  Fig. 4 C  ) or TGF-     and retinoic acid (RA;   Fig. 4 D  ). Induc-
tion of Foxp3 was markedly blunted in both Drosha- and 
Dicer-defi  cient cells, even in the presence of RA. The mag-
nitude of Foxp3 induction was similar between Drosha- and 
Dicer-defi  cient cells. The defect in Drosha- and Dicer-defi  -
cient cells was especially noticeable at lower concentrations 
of TGF-    . This defect in the ability of naive CD4  +   T cells 
from   Drosha  F/      CD4-cre   mice to up-regulate Foxp3 expres-
sion could be caused by generation of abnormal T cells that 
had been aberrantly selected in the absence of Drosha. To 
examine the requirement of Drosha-dependent pathways 
specifi  cally during inducible T reg cell diff  erentiation, naive 
    Figure 4.         Drosha- and Dicer-dependent pathways are required for 
effi  cient induction of Foxp3 expression and function of T reg cells.   
(A) Reduced TCR    + Foxp3 +   T reg cell populations in the thymus and spleen of 
  Drosha  F/    CD4-cre   and   Dicer  F/F  CD4-cre   mice. (B) Foxp3 expression in periph-
eral T reg cell populations in the absence of Drosha or Dicer. (C and D) Dro-
sha and Dicer are required for effi  cient differentiation of induced T reg cells. 
Naive CD62L  hi 44 lo 25       CD4 +   T cells from   Drosha  F/    CD4-cre ,   Dicer  F/F  CD4-cre , 
and control   Drosha  F/+  CD4-cre   mice were activated in vitro with anti-CD3/28 
antibodies plus 10 U/ml IL-2, and TGF-     (C) or TGF-     plus 10 nM RA (D) for 
3 d. The cells were restimulated with PMA/ionomycin plus GolgiStop for 3 h, 
and Foxp3 and IL-17A expression was analyzed by intracellular FACS. Per-
centages of cells are shown in A  –  D. (E) FACS-purifi  ed naive CD4  +   cells  from 
  Cd45.1   mice were loaded with CFSE and mixed with purifi  ed CD4  + 25 +   cells 
from   Drosha  F/    CD4-cre   or   Drosha  F/+  CD4-cre   ( Cd45.2  ) mice at the indicated 
ratios. These were then incubated with inactivated splenocytes and anti-
CD3 antibody. After 4 d, the CD45.1  +   cells were analyzed for CFSE dilution.    JEM VOL. 205, September 1, 2008 
ARTICLE
2011
  Drosha defi  ciency does not prevent the differentiation 
of Th1 or Th2 phenotype cells 
  It is possible that Drosha-dependent pathways may be specifi  -
cally required for the diff  erentiation and function of T reg 
cells. It is also possible that the diff  erentiation of all T cell 
subsets may be aff  ected by Drosha defi  ciency. The fi  nding 
that older   Drosha  F/      CD4-cre   mice display very high frequen-
cies of proinfl  ammatory cytokine-secreting cells suggests that 
the diff  erentiation of other Th cell subsets may not be depen-
dent on Drosha. To examine this further, naive CD4  +   T cells 
were purifi  ed from   Drosha  F/      CD4-cre   and control mice and 
were activated in vitro under Th1 (  Fig. 5 A  ) or Th2 (  Fig. 5 B  ) 
polarizing conditions.   Drosha-defi  cient naive CD4  +   T cells 
were still capable of diff  erentiating into either IFN-      –  secreting 
Th1 cells or IL-4  –  secreting Th2 cells. In fact, Drosha-defi  -
cient CD4  +   T cells consistently expressed more IFN-     than 
controls under Th1 polarizing conditions. Again, this was not 
caused by defective thymocyte diff  erentiation in   Drosha  F/      
CD4-cre   mice, because naive CD4  +   T cells from   Drosha  F/      
Rosa26  CreER/+     mice also released more IFN-     when the con-
ditional   Drosha   allele was deleted in vitro upon the addition 
of tamoxifen (Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20081219/DC1). CD8  +   T cell activation and 
IFN-     secretion did not appear to contribute to the disease 
in old   Drosha  F/      CD4-cre   mice, and CD8  +   T cells from 
these mice were capable of secreting IFN-     after activation 
in vitro (Fig. S7). 
CD4  +   T cells were purifi  ed from   Drosha  F/      Rosa26  CreER/+     mice, 
in which Cre only deletes upon the addition of tamoxifen 
(Fig. S5 A, available at http://www.jem.org/cgi/content/
full/jem.20081219/DC1). Foxp3 induction by TGF-     (Fig. 
S5 B) or TGF-     and RA (Fig. S5 C) was still blunted when 
the conditional   Drosha   allele was deleted in vitro by tamoxi-
fen addition, indicating that the observed defect was not 
caused by abnormal thymic selection. 
  Although the induction of Foxp3 expression was dra-
matically perturbed in   Drosha  F/      CD4-cre   mice, Foxp3  +  CD25  hi   
cells were still present. To examine if these cells were func-
tional, CD25  +  CD4  +   T cells were purifi  ed from   Drosha  F/      
CD4-cre   and control mice, and their ability to suppress the 
in vitro proliferation of CD25       CD4  +   T cells in response to 
APCs and anti-CD3 antibody stimulation was examined 
(  Fig. 4 E  ). CD25  +  CD4  +   T cells from   Drosha  F/      CD4-cre   
mice could partially suppress the proliferation of CD25       CD4  +   
T cells at high CD25  +  /CD25        ratios. However, this ac-
tivity was substantially reduced in comparison with that of 
CD25  +  CD4  +   T cells from control   Drosha  F/+   CD4-cre   mice. 
Thus, not only is there a reduction in T reg cell numbers 
and Foxp3 induction in   Drosha  F/      CD4-cre   mice, but the 
remaining T reg cells have reduced suppressive activity, at 
least in vitro. This suggests that a defect in the T reg cell 
compartment may be the cause of or a major contributor 
to the spontaneous infl  ammatory disease in   Drosha  F/      CD4-
cre   mice. 
    Figure 5.         Drosha defi  ciency does not prevent polarization of naive CD4  +   T cells into Th1 or Th2 cells.   Naive  CD62L hi 44 lo 25       CD4 +   T  cells 
from   Drosha  F/    CD4-cre   and control   Drosha  F/+  CD4-cre   mice were activated in vitro with anti-CD3/28 antibodies and 10 U/ml IL-2, plus (A) IL-12 and 
1   μ  g/ml anti  –  IL-4 antibody or (B) IL-4 and 1   μ  g/ml anti-IFN-     antibody for 4 d. The anti-CD3/28 antibodies were removed from the culture for the 
last 24 h, after which the cells were restimulated with PMA/ionomycin for 3 h in the presence of GolgiStop and analyzed for intracellular IFN-     and 
IL-4 expression by FACS. Percentages of cells are shown.     2012 DROSHA AND DICER REQUIREMENT FOR T REG CELL FUNCTION   | Chong et al. 
Foxp3  Cre/+     heterozygous mice, in which only half of the Foxp3  +   
cells express cre because of random X chromosome inactiva-
tion, do not develop infl  ammatory disease and remain healthy. 
This suggests that the loss of Drosha-dependent regulatory 
pathways simply abrogates the function of T reg cells, and in 
heterozygous   Drosha  F/      Foxp3  Cre/+     mice, the remaining 50% 
of T reg cells that express Drosha are suffi   cient to prevent this 
early onset disease. Furthermore, Foxp3  +   T cells from either 
moribund   Drosha  F/      CD4-cre   or   Drosha  F/      Foxp3  Cre/Cre(Y)     mice 
did not coexpress IFN-     or IL-17 (Fig. S8, available at http://
www.jem.org/cgi/content/full/jem.20081219/DC1). The 
fi  nding that both T reg cell  –  specifi  c Drosha- and Dicer-defi  -
cient mice display a phenotype identical to that of Foxp3-de-
fi  cient mice demonstrates an absolute requirement for miRNA 
pathways in the function of T reg cells. 
    DISCUSSION   
  In this study, we have shown identical phenotypes when ei-
ther the   Drosha   or   Dicer   gene was inactivated in TCR         T 
cells and in Foxp3  +   T reg cells. These results confi  rm that 
these two RNaseIII enzymes function in the same biological 
pathway in miRNA biogenesis. However, it has previously 
been shown that Dicer also functions in the biogenesis of 
other siRNAs, in addition to miRNAs (  22, 23  ), and Drosha 
was suggested to have a role in rRNA maturation (  24  ). Our 
results indicate that there is no defect in rRNA production in 
the absence of Drosha, and they are consistent with loss of 
miRNAs as the primary cause underlying the phenotypes ob-
served. Although it is quite possible that Dicer-defi  cient cells 
will also exhibit other more subtle phenotypes, such as the 
derepression of retrotransposons (  22, 23  ), it appears that it is 
miRNAs, rather than other Dicer-dependent small RNAs, 
that are critical for most cells. 
  Ablation of the miRNA biogenesis pathway late in thy-
mocyte diff  erentiation, either by deleting   Drosha   or   Dicer  , did 
not prevent the development or maintenance of a peripheral 
mature T cell pool. Similarly, deletion of Dicer in terminally 
diff  erentiated pancreatic      cells (  20  ) or in dopaminoceptive 
postmitotic neurons (  34  ) did not result in the loss of these 
cells. Instead, functional defects were manifest in these cells. 
In the case of the T cell compartment, a functional defect was 
particularly prominent in the T reg lineage. Either Drosha or 
Dicer defi  ciency led to defective Foxp3 induction and sup-
pressive activity in these cells. Loss of miRNA biogenesis in 
T reg cells had a devastating eff  ect on the survival of mice 
when the rest of the immune system was miRNA compe-
tent. Even though Foxp3  +   cells were still present in   Drosha  F/      
Foxp3  Cre/Cre(Y)     and   Dicer  F/F   Foxp3  Cre/Cre(Y)     mice, the animals 
succumbed to autoimmune lymphoproliferative disease 
indistinguishable from that in mice that lack Foxp3  +   cells or 
a functional   Foxp3   gene. Even in   Drosha  F/      CD4-cre   mice, in 
which all T cells lacked the ability to generate mature 
miRNAs, spontaneous lethal infl  ammatory disease still en-
sued, albeit much later in life. This indicates that miRNAs are 
indispensable for the function of T reg cells. This is unlike what 
has been described for some cell types, such as postmitotic 
  Thus, it appears that the defective T reg cell diff  erentia-
tion and function, together with the normal or enhanced dif-
ferentiation of conventional CD4  +   T cells into proinfl  ammatory 
subsets, may be the mechanism underlying the spontaneous 
infl  ammatory disease and premature mortality in   Drosha  F/      
CD4-cre   mice. 
  Drosha- and Dicer-dependent pathways are indispensable 
within the T reg cell compartment 
  To determine if defective T reg cells enhanced Th1 cell dif-
ferentiation, or if both are required for spontaneous infl  am-
matory disease in   Drosha  F/      CD4-cre   mice, we examined the 
eff  ect of inactivating the   Drosha   gene specifi  cally in T reg 
cells. Mice with IRES-Cre knocked into the X-linked   Foxp3   
gene were used for T reg cell  –  specifi  c deletion (  31  ). Both fe-
male mice homozygous for and male mice hemizygous for 
the Cre insertion were examined, and alleles for both are 
designated as   Foxp3  Cre/Cre(Y)    . Both   Drosha  F/      Foxp3  Cre/Cre(Y)     and 
  Dicer  F/F   Foxp3  Cre/Cre(Y)     mice became sick at 2  –  3 wk of age, 
with a 100% mortality rate (  Fig. 6 A  ).   Sick   Drosha  F/      Foxp3  Cre/Cre(Y)     
mice displayed massive lymphadenopathy and, to a lesser ex-
tent, splenomegaly (  Fig. 6, B and C  ). In moribund mice, all 
leukocyte populations appeared to have expanded equally, 
except for a consistent increase in the frequency of CD8  +   
T cells (  Fig. 6 D  ). Increases in the frequencies of CD62L  lo  44  hi   
CD4  +   and CD8  +   T cells were observed, suggesting aberrant 
activation (  Fig. 6 E  ). Hyper  –  IFN-     secretion by both CD4  +   
and CD8  +   T cells, and hyper  –  IL-4 secretion by CD4  +   T cells 
were also observed in these mice (  Fig. 6, F and G  ). Large areas 
of the liver and lung were infi  ltrated by infl  ammatory cells 
in moribund   Drosha  F/      Foxp3  Cre/Cre(Y)     mice (  Fig. 6 J  ; and 
Table S2, available at http://www.jem.org/cgi/content/full/
jem.20081219/DC1). Cuffi   ng around blood vessels was also 
observed in other tissues, including the pancreas, kidney, and 
skeletal muscle. This phenotype is identical to mice lack-
ing   Foxp3   or Foxp3-expressing cells (  2, 3  ). This pheno-
type was also recapitulated in   Dicer  F/F   Foxp3  Cre/Cre(Y)     mice 
(unpublished data). 
  This early lymphoproliferative phenotype was not caused 
by a loss of T reg cells but rather by loss of function, because 
Foxp3  +   cells could still be detected in these mice (  Fig. 6, H 
and I  ). In fact, the T reg cell phenotype in these mice was 
similar to that in   Drosha  F/      CD4-cre   mice. There was a reduc-
tion of the Foxp3  +  CD25  lo   population, but Foxp3  +  CD25  hi   
cells were present. 
  It has previously been suggested that Foxp3  +   T reg cells 
express a high frequency of high-affi   nity self-reactive TCRs 
(  32  ). This hypothesis remains controversial, as a more recent 
analysis found that TCRs derived from T reg and non  –  T reg 
cells recognize foreign peptide  –  MHC complex with similar 
frequencies (  33  ). Nevertheless, if a subset of Foxp3  +   cells 
does express self-reactive TCRs, Drosha defi  ciency poten-
tially may not only abrogate suppressive activity but also allow 
for activation through such TCRs. Thus, a Foxp3  +   popula-
tion itself may be responsible for this infl  ammatory phenotype 
in   Drosha  F/      Foxp3  Cre/Cre(Y)     mice. However, female   Drosha  F/      JEM VOL. 205, September 1, 2008 
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    Figure 6.         T reg cell  –  specifi  c Drosha or Dicer defi  ciency recapitulates the   scurfy   phenotype.   (A) Kaplan-Meyer survival plot of   Drosha  F/     
Foxp3  Cre/Cre(Y)  ,   Dicer  F/F   Foxp3 Cre/Cre(Y)   , and control mice (  Drosha  F/+   Foxp3 Cre/Cre(Y)  ,   Drosha  F/      Foxp3 Cre/+  ,   Drosha  F/+   Foxp3 Cre/+  ,  Dicer  F/+   Foxp3 Cre/Cre(Y)  ,  and 
  Dicer  F/+   Foxp3 Cre/+   ). (B) Massive lymphadenopathy in a female   Drosha  F/      Foxp3 Cre/Cre    mouse. Shown are the cervical lymph nodes. (C) Cell counts of 
lymphoid organs from moribund   Drosha  F/      Foxp3 Cre/Cre    or   Drosha  F/      Foxp3 Cre/Y    mice and littermate controls. Data represent the mean   ±   SD of four 
mice at 2.5  –  3 wk of age. (D) Only marginal changes in the proportions of B (CD19  + ),      T  (TCR     +  ), myeloid (CD11b  +  ), and T cells (TCR    +  ) in the 
spleen and lymph nodes of   Drosha  F/    Foxp3 Cre/Cre    mice. (E) Aberrant T cell activation in the spleen and lymph nodes of moribund   Drosha  F/    Foxp3 Cre/Cre   
mice. (F and G) Cytokine expression by CD8  +   (F) and CD4  +   (G) T cells from   Drosha  F/      Foxp3 Cre/Cre    mice. (H and I) Foxp3 expression in total spleno-
cytes (H) and CD4  +   T cells (I). Percentages of cells are shown in D  –  I. (J) H  &  E-stained sections of the lung (i and iii) and liver (ii and iv). Designation 
of   Foxp3  Cre/Cre(Y)    alleles indicates that both males and females were included in the experiments. Bars, 100   μ  m.     2014 DROSHA AND DICER REQUIREMENT FOR T REG CELL FUNCTION   | Chong et al. 
ation in   Drosha CD4-cre   mice. Indeed, both Drosha-defi  -
cient CD4  +   and CD8  +   T cells displayed reduced proliferation 
in vitro in response to anti-CD3 stimulation, but this was 
overcome when anti-CD28 co-stimulation was provided 
(Fig. S9 A, available at http://www.jem.org/cgi/content/
full/jem.20081219/DC1). Furthermore, these cells also pro-
liferated marginally slower than wild-type cells when adop-
tively cotransferred into the same lymphopenic Rag-defi  cient 
hosts (Fig. S9 B). 
  miRNAs may be involved in regulating TCR signaling 
and/or proliferation in conventional T cells. One miRNA, 
miR-181a, has previously been shown to modulate TCR 
sensitivity (  38  ). Increasing the levels of miR-181a in T cells 
was found to lower the threshold of signaling. Thus, loss of 
miR-181a may render T cells less sensitive to TCR engage-
ment. In   Drosha  F/      Foxp3  Cre/Cre(Y)     and   Dicer  F/F   Foxp3  Cre/Cre(Y)     
mice, there was a dramatic expansion of all leukocytes, as has 
been previously shown in mice with mutations in   Foxp3   or 
lacking Foxp3  +   cells   2  –  4  . However, in moribund   Drosha  F/      
CD4-cre   mice, there were only increases in Gr-1  +   and         T 
cells without lymphoproliferation, despite only T cells being 
defective for miRNA biogenesis. This suggests that the gen-
eralized lymphoproliferation and lymphadenopathy in   Dro-
sha  F/      Foxp3  Cre/Cre(Y)    ,  Dicer  F/F   Foxp3  Cre/Cre(Y)    , or Foxp3-defi  cient 
mice is entirely secondary to the activation of T cells. 
  Another diff  erence was the appearance of IFN-      +    –   and 
IL-17A  +    –   but not IL-4  –  producing CD4  +   T cells in moribund 
  Drosha  F/      CD4-cre   mice, whereas IFN-      –   and IL-4  –  producing 
cells were dominant in   Drosha  F/      Foxp3  Cre/Cre(Y)     mice. The dif-
ferentiation of IL-17A  +   cells in   Drosha  F/      CD4-cre   mice may 
be related to the inability of Drosha-defi  cient conventional T 
cells to rapidly proliferate and up-regulate IFN-     and IL-4 in 
the perinatal period, as occurs in   Drosha  F/      Foxp3  Cre/Cre(Y)     
mice. The massive expansion of Th1 and Th2 cells in the lat-
ter case may inhibit the diff  erentiation of Th17 cells. 
  This study has clearly demonstrated a critical requirement 
for miRNA-dependent regulation in the prevention of spon-
taneous infl  ammation/autoimmunity. Might polymorphisms 
or mutations in miRNA machinery components or specifi  c 
miRNA genes contribute to infl  ammatory or autoimmune 
disease in humans? Although mutations in this pathway have 
not yet been identifi  ed in humans with autoimmune disease, 
it has been shown that miR-17-92 overexpression in mice 
leads to spontaneous autoimmunity (  39  ). A link to human 
disease, however, has been made for Drosha. Expression of 
Drosha, but not Dicer or DGCR8, is up-regulated in cervical 
squamous cell carcinomas and esophageal tumors (  40, 41  ). 
Furthermore, the oncogenic ALL-1 fusion proteins have been 
shown to recruit Drosha to specifi  c miRNA loci in leukemic 
cells lines (  42  ), which may underlie the overexpression 
of certain miRNAs in leukemia. There is now a signifi  cant 
body of evidence correlating mutations or misexpression 
of miRNAs with numerous human cancers (  43  ). Thus, 
continued eff  orts to gain a better understanding of miRNA 
biogenesis and function will undoubtedly provide signifi  cant 
insight into human disease. 
Purkinje neurons, in which the loss of Dicer activity results 
in cell death (  35  ). Why the loss of miRNA-dependent regu-
lation in some cell types results in cell death instead of func-
tional perturbations is unclear. It may be that neurodegeneration 
is secondary to the loss of function. Alternatively, compo-
nents of the apoptotic machinery may be subject to miRNA-
dependent regulation (  21  ). 
  How might miRNAs enable a T reg cell to be immuno-
suppressive? T reg cells have been postulated to act via a 
myriad of mechanisms. These include secretion of immuno-
modulatory cytokines, such as TGF-     and IL-10, modula-
tion of co-stimulatory molecules on antigen-presenting cells, 
cytotoxic T lymphocyte antigen 4  –  induced tryptophan ca-
tabolism and direct cytotoxicity (  36  ). Both in vitro and in 
vivo studies have provided compelling evidence that all of 
these and other mechanisms contribute to T reg cell  –  medi-
ated immunosuppresion. However, abrogation of any one 
mechanism does not signifi  cantly impair the function of these 
cells. Even the ablation of IL-10 production by T reg cells 
results in only mild infl  ammation at mucosal surfaces (  31  ). It 
is likely that T reg cells use multiple mechanisms to maintain 
immune homeostasis. Ablation of miRNA biogenesis is the 
fi  rst example that completely phenocopies the loss of Foxp3  +   
cells. This suggests that miRNAs may concurrently modulate 
multiple pathways in T reg cells, and the loss of this mod-
ulation may in eff  ect abrogate multiple immunosuppressive 
mechanisms used by these cells. In addition to conferring 
some of the immunosuppressive properties of T reg cells (  37  ), 
Foxp3 itself has been shown to be responsible for a signifi  cant 
component of the miRNA signature in these cells (  28  ). Be-
cause miRNA pathways are also required for inducing and 
maintaining Foxp3 expression, this suggests that there is a 
positive feedback loop between Foxp3 and miRNAs that is 
critical for the function of T reg cells. Interestingly, like many 
other markers of T reg cells such as CD25, cytotoxic T lym-
phocyte antigen 4, and glucocorticoid-induced TNFR, a T 
reg cell miRNA signature is also induced in naive CD4  +   T 
cells after TCR activation (  28  ). 
  Although spontaneous infl  ammatory disease appeared to 
be related to a loss of T reg cell function in both   Drosha  F/      
Foxp3  Cre/Cre(Y)     and   Drosha  F/      CD4-cre   mice, only in the former 
was there massive lymphoproliferative disease, whereas lym-
phopenia occurred in the latter. The striking diff  erence be-
tween the lifespans of   Drosha  F/      Foxp3  Cre/Cre(Y)     and   Drosha  F/      
CD4-cre   mice suggests that diff  erent mechanisms may be in-
volved in the two diseases. It is clear that Drosha-dependent 
pathways are required for T reg cell function. However, the 
fi  nding that the conventional T cells in   Drosha  F/      CD4-cre   
mice did not proliferate inappropriately to cause lymphade-
nopathy and early onset disease like the Drosha-suffi   cient 
conventional T cells in   Drosha  F/      Foxp3  Cre/Cre(Y)     mice suggests 
that Drosha-defi  cient T cells are also defective in some way, 
even though they are able to polarize into infl  ammatory 
eff  ector cells both in vitro and in vivo  .   One possible defect 
may be the proliferative potential of Drosha-defi  cient T cells, 
as suggested by the lymphopenia rather than lymphoprolifer-JEM VOL. 205, September 1, 2008 
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exon 9/10. 5    -CACAGCTTCTTTGCAGCTCCTT-3     and 5    -CGTC-
ATCCATGGCGAACTG-3     were used to amplify     -actin as a control. 
  Western blotting.     Cells were lysed in 50 mM Tris (pH 8), 150 mM NaCl, 
1% NP-40, and protease inhibitors, and the insoluble components were re-
moved by centrifugation. The equivalent of 2   ×   10  6   cells was resolved on a 
7% polyacrylamide gel and immunoblotted with a rabbit polyclonal anti-
body against the N terminus of Drosha (Millipore) or a mouse monoclonal 
antibody against     -tubulin (Invitrogen). 
  FACS analyses.     Analyses were performed on an LSRII (BD Biosciences). 
All antibodies were purchased from eBioscience or BD Biosciences. For the 
detection of intracellular cytokine expression, total cells were restimulated in 
vitro with 50 ng/ml PMA and 1   μ  M ionomycin for 3 h in the presence of 
GolgiStop (BD Biosciences). After staining for cell surface markers, the cells 
were fi  xed and permeabilized with Cytofi  x/Cytoperm (BD Biosciences) and 
stained for cytokine expression. Detection of intranuclear Foxp3 expression 
was performed by fi  xation and permeabilization with Foxp3 fi  xation/per-
meabilization buff  er (eBioscience) before staining for Foxp3. 
  In vitro T cell culture.     FACS-purifi  ed T cells were activated in vitro 
with 5   μ  g/ml of plate-bound anti-CD3 and 1   μ  g/ml of soluble anti-CD28 
antibodies in RPMI supplemented with 10% FCS, 5 mM     -mercaptoeth-
anol, and antibiotics. Cells were plated at a density of 5   ×   10  5  /ml at day 0 
of culture. Various cytokines and neutralizing antibodies were added at 
day 0 or 1 of culture. All cytokines and antibodies were purchased from 
PeproTech or eBioscience. 
  For in vitro suppression assays, naive (CD62L  hi  44  lo  25       ) CD4  +   T cells 
(eff  ectors) were FACS purifi  ed from   Cd45.1   mice and loaded with 5   μ  M 
CFSE (Invitrogen), and mixed with FACS-purifi  ed CD25  +  CD4  +   T reg 
cells at various ratios. Total splenocytes from C57BL/6 mice inactivated 
with 50   μ  g/ml mitomycin C (Sigma-Aldrich) for 45 min were used as 
APCs. A total of 4   ×   10  5   CD4  +   cells (CFSE-loaded CD25        plus CD25  +  ) 
was mixed with 10  5   APCs plus 1   μ  g/ml anti-CD3 antibody per well of a 
96-well round-bottom plate. Proliferation of the   Cd45.1   eff  ector cells was 
analyzed by CFSE dilution. 
  T cell transfers.     CD45.1 and CD45.2 congenically marked cells were 
mixed at a 1:1 ratio and loaded with CFSE. The cells were resuspended in 
PBS at 10  8   cells/ml, and a total of 10  7   cells were transferred into   Rag2      /        re-
cipients by injection into the retroorbital plexus. 
  Online supplemental material.     Fig. S1 shows that multiple Drosha splice 
isoforms are expressed in mouse tissues. Fig. S2 depicts the generation of the 
conditional   Drosha   allele. Fig. S3 shows the accumulation of infl  ammatory 
cytokine-producing CD4  +   T cells in the spleens of aging   Drosha  F/      CD4-cre   
mice. Fig. S4 depicts moribund   Drosha  F/      CD4-cre   mice that do not develop 
splenomegaly or lymphadenopathy. Fig. S5 shows that defective TGF-      –  in-
duced Foxp3 expression in the absence of Drosha is not due to thymocyte 
selection defects. Fig. S6 shows that enhanced IFN-     expression in Drosha-
defi  cient CD4  +   cells is not due to thymocyte selection defects. Fig. S7 de-
picts the induction of IFN-     expression in Drosha-defi  cient CD8  +   cells. Fig. 
S8 shows that Foxp3 is not coexpressed with IFN-     or IL-17A in moribund 
  Drosha  F/      CD4-cre   or   Drosha  F/      Foxp3  Cre/Cre(Y)     mice. Fig. S9 shows that Dro-
sha-defi  cient T cells display a partial proliferation defect in response to TCR 
stimulation or lymphopenia. Table S1 provides a tissue survey of moribund 
  Drosha  F/      CD4-cre   mice. Table S2 provides a tissue survey of moribund 
  Drosha  F/      Foxp3  Cre/Cre(Y)     mice. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20081219/DC1. 
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  MATERIALS AND METHODS 
  Mice.     A targeting construct containing exon 9 of Drosha fl  anked by LoxP 
sites and a LopP-fl  anked neomycin selection cassette (Neo) was assembled 
from genomic fragments subcloned from the bacterial artifi  cial chromosome 
clone RP23-354M9. A LoxP-  exon9  -LoxP-Neo-LoxP confi  guration was used 
such that cre-mediated recombination between the 5     and middle LoxP sites 
would yield a conditional allele, whereas recombination between the 5     and 3     
LoxP sites would yield a null allele. EcoRI and SacI sites were inserted at the 
5     and 3     LoxP sites, respectively, to allow for screening by Southern blotting. 
The construct was targeted into E14 129Sv-derived embryonic stem cells, 
from which mice were derived. These were bred with EIIA-cre mice, which 
transiently express cre in the early embryo, to obtain progeny harboring either 
the conditional or the null allele, and were then backcrossed onto the C57BL/6 
genetic background for four more generations. 
    Dicer  F/F     (provided by M. McManus, University of California, San Fran-
cisco, San Francisco, CA) (  44  ),   CD4-cre   (  25  ), and   Foxp3  Cre     (  31  ) mice have 
previously been described.   EIIA-cre  ,   Rosa26  CreER    , and   Cd45.1   mice were 
purchased from Jackson ImmunoResearch Laboratories, and   Rag2      /        mice 
were purchased from Taconic. The mice were housed in specifi  c pathogen-
free conditions at the animal facility of the Skirball Institute. All animal ex-
periments were performed in accordance with approved protocols for the 
New York University Institutional Animal Care and Usage Committee. 
  Organ preparation and cell purifi  cations.     Lymphocytes were prepared 
from thymi, spleens, and lymph nodes by grinding the organs through a 100-
  μ  m mesh. Red blood cells were removed from splenic cell suspensions by 
lysis with ACK buff  er (BioWhittaker). Lymphoid populations were enriched 
by MACS magnetic bead purifi  cation (Miltenyi Biotec) and sorted to high 
purity on a FACSAria (BD Biosciences). Organs for histological analyses 
were fi  xed in 10% buff  ered formalin, dehydrated, and paraffi   n embedded 
before sectioning and staining with hematoxylin and eosin (H  &  E). 
  Southern and Northern blotting.     Genomic DNA was prepared from 
cells by standard techniques and digested overnight with restriction en-
zymes. DNA fragments were resolved on a 0.7% agarose gel before transfer 
onto a membrane (Hybond-XL; GE Healthcare), and were probed with 
radiolabeled DNA probes. 
  Total RNA was purifi  ed using TRI  zol   (Invitrogen) according to the 
manufacturer  ’  s protocol, with one modifi  cation: RNAs were precipitated 
from the aqueous phase using 2  ×   volumes of ethanol at     80  °  C for 1 h 
before centrifugation. Detection of small RNA species was performed by 
resolving 10   μ  g of total RNA on a 15% polyacrylamide gel and Northern 
blotting with radiolabeled oligonucleotide probes, as previously described 
(  45  ). For the detection of long RNA species, 20   μ  g of total RNA was re-
solved on a 1% formaldehyde agarose gel before Northern blotting with 
a radiolabeled oligonucleotide probe. Northern blotting was performed 
with the following probes: 5    -TAACCGATTTCAGATGGTGCTA-3     
(miR-29a), 5    -AGTAGTGCTTTCTACTTTATG-3     (miR-142-5p), 5    -
TCCATAAAGTAGGAAACACTACA-3     (miR-142-3p), and 5    -CACT-
GGTACAAGGGTTGGGAGA-3     (miR-150). 
  RT-PCRs.     First-strand RT was performed on total RNA using Super-
script II (Invitrogen). The following forward primers were used to detect 
specifi  c exon boundaries in the Drosha cDNA: 5    -GGCTGGGCTTT-
GATGGCGGCGACCCCGGGA-3     (exon 1 forward), 5   -AACCTAC  A  T-
CGTGAGCGGAAGATGTAGCCT-3     (exon 3 forward), 5    -GACCCCAA-
AACCTGCGACTTCTTCATC-3     (exon 4), 5   -GCAGATCACCG  T  C  T-
CTAGAAA-3     (exon 5), 5    -GCACACCAGAGTTGCCTGGGGAGAT-
GATTA-3     (exon 6), and 5   -AAGCAGGCTCCGTGATTTGTATGAC-3     
(exon 8), with the reverse primer 5    -CTCTTCTCCGGGATAAATGCT-
GTGG-3     (exon 10). 
  The following primer pairs were used to detect Drosha exon boundaries 
by quantitative PCR: 5    -TGCAAGGCAATACGTGTCAT-3     and 5    -
GGCCTGAGAGTTCGAGTAGG for exon 3/4; and 5    -GACGACGA-
CAGCACCTGTT-3     and 5    -GATAAATGCTGTGGCGGATT-3     for 2016 DROSHA AND DICER REQUIREMENT FOR T REG CELL FUNCTION   | Chong et al. 
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